Chapter
The Giant Company and Giant Government Collaboration That Can Box Out Small Startups and Small Countries
3:31:40 - 3:35:43 (04:02)
The partnership between big government and big companies can prevent small companies and small countries from progressing, limiting innovation and regulation outsourcing. Career tenures for regulators take them out of reach of the electorate.
Clips
Small companies outsource their login to Facebook for easier management, similarly, small countries outsource their regulation to the USA as creating a new country is easier than reforming the FDA.
3:31:40 - 3:33:22 (01:41)
Summary
Small companies outsource their login to Facebook for easier management, similarly, small countries outsource their regulation to the USA as creating a new country is easier than reforming the FDA. However, regulatory harmonization could be the worst thing in the world.
ChapterThe Giant Company and Giant Government Collaboration That Can Box Out Small Startups and Small Countries
Episode#331 – Balaji Srinivasan: How to Fix Government, Twitter, Science, and the FDA
PodcastLex Fridman Podcast
Some positions in our democracy, including tenured professors and regulatory officials, are not subject to democratic accountability and global regulation benefits big pharmaceutical companies.
3:33:22 - 3:34:09 (00:47)
Summary
Some positions in our democracy, including tenured professors and regulatory officials, are not subject to democratic accountability and global regulation benefits big pharmaceutical companies.
ChapterThe Giant Company and Giant Government Collaboration That Can Box Out Small Startups and Small Countries
Episode#331 – Balaji Srinivasan: How to Fix Government, Twitter, Science, and the FDA
PodcastLex Fridman Podcast
The FDA denied people the ability to run COVID tests through its Emergency Use Authorization process, which led to confusion and lack of COVID cases reported in the US during the early stages of the pandemic.
3:34:09 - 3:35:43 (01:33)
Summary
The FDA denied people the ability to run COVID tests through its Emergency Use Authorization process, which led to confusion and lack of COVID cases reported in the US during the early stages of the pandemic. This caused a pushback against the government and FDA from small startups and countries that were being boxed out from innovation.